Generic Pharmaceuticals Market with COVID-19 Impact Analysis, By Type (Simple Generics, Specialty Generics, Biosimilars), By Route of Administration (Oral, Injectable, Inhalable, and Others), By Product (Small Molecule and Large Molecule), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, and Others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Generic Pharmaceuticals Market size was valued at USD 361701.0 Million in 2022, expanding at a CAGR of 8.31% from 2023 to 2030.
Generic medicines are non-branded drugs with the same active components, dosage form, potency, and intended purpose as brand-name drugs. Following the termination of the patent protection for the original medicine, these products are created and marketed. To assure their safety, quality, and efficacy, generic medications must pass stringent regulatory clearance procedures. Generic medicines are often less expensive than name-brand medications since there are no expenditures associated with research and development. While preserving similar therapeutic efficacy to their branded versions, they help extend access to vital pharmaceuticals and are crucial in lowering healthcare costs.
Generic Pharmaceuticals Market- Market Dynamics
- Increasing incidence of chronic diseases
The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceutical market. As more people are given a chronic disease diagnosis, they seek out additional medications to treat it. Branded medications cost more, whereas generic medications cost less and share the same chemical make-up as branded medications. Patients choose generic medications over branded medications due to the lower cost, consistency in chemical makeup, and potency of generic medications. As a result of the extended duration of therapy for chronic diseases, generic medicine sales also rise. For instance, the WHO (World Health Organization) predicts a 17% rise in the number of chronic disease-related fatalities during the next ten years.
Generic Pharmaceuticals Market- Key Insights
- As per the analysis shared by our research analyst, the global paper bags packaging market is estimated to grow annually at a CAGR of around 8.31% over the forecast period (2023-2030)
- The paper bags packaging industry is projected to grow at a significant rate due to the growing incidence of chronic diseases
- Based on type segmentation, simple generic products were predicted to show maximum market share in the year 2022
- Based on application, cardiovascular was the leading type in 2022
- Based on product segmentation, the small molecule was the leading type in 2022
- Based on route of administration segmentation, oral was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Generic Pharmaceuticals Market- Segmentation Analysis:
The Global Generic Pharmaceuticals Market is segmented on the basis of Type, Route of Administration, Application, and Region.
The market is divided into categories based on Type: Simple Generics, Specialty Generics, and Biosimilars. The Simple Generics sector dominates the market. The simple generic products need to conduct bioequivalence studies and have a defined development plan and regulatory approach. These items are chemically identical to their reference counterparts, and the market is already overflowing with straightforward generic products. Nevertheless, the market is anticipated to expand as a result of government attempts to cut healthcare spending on medicines and increase new approvals and launches.
The market is divided into categories based on Route of Administration: Oral, Injectable, Inhalable, and Others. The oral segment dominates the market. The many benefits of oral dose, including its simplicity and lack of nursing needs, increase patient acceptance and compliance. For the treatment of COVID-19 patients, Zenera Pharma introduced a generic version of Paxlovid in September 2022. Each box of these oral medications, which contains 20 Nirmatrelvir pills, costs USD 63.74.
Generic Pharmaceuticals Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. An increasing number of favorable government initiatives coupled with the rising number of product launches and demand for generic drugs is a key revenue driver in North American region.
Generic Pharmaceuticals Market- Competitive Landscape:
Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, Product network development, R&D spending, and mergers and acquisitions. For instance, in November 2022, The US health authority gave Glenmark Pharmaceuticals permission to sell sodium phenylbutyrate tablets, a medication used to treat urea cycle disorders, in the US.
Recent Developments:
- In October 2022, Generic Fingolimod capsules, utilized for the treatment of multiple sclerosis, were introduced to the American market by Glenmark\'s American-based division.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENERIC PHARMACEUTICALS MARKET KEY PLAYERS
- Zydus Cadila
- Torrent Pharmaceuticals
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Sandoz (a subsidiary of Novartis)
- Mylan (now part of Viatris)
- Lupin Pharmaceuticals
- Hikma Pharmaceuticals
- Glenmark Pharmaceuticals
- Fresenius Kabi
- Endo International (through its subsidiary Par Pharmaceutical)
- Reddy\'s Laboratories
- Cipla
- Aurobindo Pharma
- Apotex
GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE
- Simple Generics
- Specialty Generics
- Biosimilars
GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION
- Oral
- Injectable
- Inhalable
- Others
GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT
- Small Molecule
- Large Molecule
GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION
- Central Nervous System Disorders
- Respiratory Diseases
- Hormones & Related Diseases
- Gastrointestinal Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Cancer
- Diabetes
- Others
GLOBAL GENERIC PHARMACEUTICALS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Generic Pharmaceuticals Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Generic Pharmaceuticals Market Snippet by Type
2.1.2. Generic Pharmaceuticals Market Snippet by Route of Administration
2.1.3. Generic Pharmaceuticals Market Snippet by Product
2.1.4. Generic Pharmaceuticals Market Snippet by Application
2.1.5. Generic Pharmaceuticals Market Snippet by Country
2.1.6. Generic Pharmaceuticals Market Snippet by Region
2.2. Competitive Insights
3. Generic Pharmaceuticals Key Market Trends
3.1. Generic Pharmaceuticals Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Generic Pharmaceuticals Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Generic Pharmaceuticals Market Opportunities
3.4. Generic Pharmaceuticals Market Future Trends
4. Generic Pharmaceuticals Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Generic Pharmaceuticals Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Generic Pharmaceuticals Market Landscape
6.1. Generic Pharmaceuticals Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Generic Pharmaceuticals Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. Simple Generics
7.1.3. Specialty Generics
7.1.4. Biosimilars
8. Generic Pharmaceuticals Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
8.1.2. Oral
8.1.3. Injectable
8.1.4. Inhalable
8.1.5. Others
9. Generic Pharmaceuticals Market – By Product
9.1. Overview
9.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
9.1.2. Small Molecule
9.1.3. Large Molecule
10. Generic Pharmaceuticals Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
10.1.2. Central Nervous System Disorders
10.1.3. Respiratory Diseases
10.1.4. Hormones & Related Diseases
10.1.5. Gastrointestinal Diseases
10.1.6. Cardiovascular Diseases
10.1.7. Infectious Diseases
10.1.8. Cancer
10.1.9. Diabetes
10.1.10. Others
11. Generic Pharmaceuticals Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Generic Pharmaceuticals Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Generic Pharmaceuticals Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Generic Pharmaceuticals Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Generic Pharmaceuticals Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Generic Pharmaceuticals Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Generic Pharmaceuticals Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Zydus Cadila
12.2.2. Torrent Pharmaceuticals
12.2.3. Teva Pharmaceutical Industries
12.2.4. Sun Pharmaceutical Industries
12.2.5. Sandoz (a subsidiary of Novartis)
12.2.6. Mylan (now part of Viatris)
12.2.7. Lupin Pharmaceuticals
12.2.8. Hikma Pharmaceuticals
12.2.9. Glenmark Pharmaceuticals
12.2.10. Fresenius Kabi
12.2.11. Endo International (through its subsidiary Par Pharmaceutical)
12.2.12. Dr. Reddy\'s Laboratories
12.2.13. Cipla
12.2.14. Aurobindo Pharma
12.2.15. Apotex
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
